Biotechnology, one of molecular biology’s branches, monitored and intentional manipulation of biological organisms, processes or systems to effectively make or process drugs, or any other products and substances useful to enhancing people’s living quality. The earliest examples of humans applying their knowledge of biotechnology involved the efforts to enhance plants and animals’ species by cross-pollination (allogamy) or cross-breeding.
Biotechnology has recently turned to a more sophisticated business, considerably enlarged in scale and application range. Having goodly restored from the recession, the world Biotechnology Market is anticipated to be eventually estimated at far over EUR 245 billion by end-2015. However, with the numerous benefits this advanced technology comes laden with, there are worries about its potential misuse. Concerns over this issue has trailed into some attempting to facilitate the enforcement of specific laws constraining or even banning relevant programs and research (e.g. human cloning).
The research reports from this Catalogue offer a comprehensive outlook on the worldwide Biotechnology Market. The reports identify major market challenging forces and growth drivers, provide fresh statistics on the Biotechnology Industry, outline various trends and factors specifying the market’s direction, and more. Regional and country markets’ reviews are at hand in the reports too. Furthermore, companies with their innovations are discussed, and also short to long term forecasts are provided in the researches.
Publications found:
1,817
Sort by:
North America Biosimilars Market 2020-2030 by Product Type (Non-glycosylated, Glycosylated), Indication (Cancer, Autoimmune Disease, Blood Disorder, Diabetes), Manufacturing (Contract, Inhouse), End User (Hospitals and Clinics, Research Institutes), and Country: Trend Forecast and Growth Opportunity
US$ 2,295.00
North America biosimilars market is expected to grow by 25.1% annually in the forecast period and reach $27.57 billion by 2030 driven by the affordability of biosimilar-based treatment, rising inciden...
November 2021
116 pages
Asia Pacific BOPP and BOPET films Market Analysis: Plant Capacity, Production, Operating Efficiency, Process, Demand & Supply, Application, Sales Channel, Region, Competition, Trade, Customer & Price Intelligence Market Analysis, 2015-2030
US$ 4,000.00
Asia Pacific BOPP and BOPET films demand stood at 2.09 Million Tonnes in 2020 and is forecast to reach 3.476 Million Tonnes by 2030, growing at a healthy CAGR of 5.04% until 2030. The rise in e-commer...
June 2021
-
Stem Cell Therapy Market by Type (Allogeneic, Autologous), Therapeutic Application (Musculoskeletal, Wound & Injury, CVD, Autoimmune & Inflammatory), Cell Source (Adipose tissue, Bone Marrow, Placenta/Umbilical Cord) - Global Forecasts to 2026
US$ 4,950.00
... of allogeneic stem cells, easier production scale-up due to easy availability of sources of stem cells, and growing number of clinical trials of allogeneic stem cell therapies as compared to autologous stem cell therapies. The stem cell therapy market is niche ...
April 2021
155 pages
Biomaterials Market by Type of Materials (Metallic, Ceramic, Polymers, Natural), Application (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Neurological disorders, Tissue Engineering, Ophthalmology) - Global Forecast to 2025
US$ 4,950.00
... the forecast period. Based on type, the biomaterials market is segmented into metallic, polymeric, ceramic, and natural biomaterials. The polymeric biomaterials segment is expected to grow at the ...
January 2021
299 pages
Global Glycobiology Market, By Product (Enzymes, Instruments, Reagents and Kits), By Application (Drug Discovery, Disease Diagnostics, Virology, Cell Biology, Oncology, Others), By End User (Research Institutes, Diagnostic Centers, Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Others), By Region, Competition, Forecast & Opportunities, 2025
US$ 4,500.00
Global glycobiology market was valued at USD 938.76 Million in 2019 and is expected to grow at a double digit CAGR of 13.83% during the forecast period. The global glycobiology market is driven by the...
January 2021
224 pages
Global Human Organoids Market by Product (Pancreas, Kidney, Lung, GIT, Liver Models) Usability (Customized, Ready-To-Use), Application (Toxicity, Pathology, Personalized & Regenerative Medicine), End-user (Pharma-Biotech, CROs, Academia) and Regional Forecasts 2020-2027
US$ 3,750.00
Global Human Organoids Market is valued approximately at USD 723.40 million in 2019 and is anticipated to grow with a healthy growth rate of more than 17.5 % over the forecast period 2020-2027. Organo...
December 2020
200 pages
Stem Cell Umbilical Cord Blood Market by Storage Service (Public Cord Blood Banks, Private Cord Blood Banks, and Hybrid Cord Blood Banks), Therapeutics (Cancer, Diabetes, Blood Diseases, Immune Disorders, Metabolic Disorders, and Other Diseases), and Application( Transplant Medicine and Regenerative Medicine): Global Opportunity Analysis and Industry Forecast, 2020–2027
US$ 5,769.00
The global stem cell umbilical cord blood market was valued at $3,110.8 million in 2019, and is projected to reach $10,135.20 million by 2027, registering a CAGR of 16.9% from 2020 to 2027. Presently,...
August 2020
209 pages
Biosimilars Market by Product (Insulin, rhGH, Granulocyte colony-stimulating factor, Interferon, Erythropoietin, Etanercept, Monoclonal antibodies, Follitropin, Glucagon, Calcitonin, Teriparatide, and Enoxaparin Sodium), By Manufacturing (In-house, Contract) & Indication (Offsite Treatment, Oncology, Chronic Disease, Blood Disorder, Autoimmune Disease, Blood Disorders, Infectious Disease, and Other Diseases), By Geography (North America, Europe, APAC, and RoW) Global Opportunity Analysis and Industry Forecast up to 2026
US$ 3,250.00
Biosimilars Market by Product (Insulin, rhGH, Granulocyte colony-stimulating factor, Interferon, Erythropoietin, Etanercept, Monoclonal antibodies, Follitropin, Glucagon, Calcitonin, Teriparatide, and...
July 2020
85 pages
Global Biosimilars - Market and Technology Forecast to 2028
US$ 3,995.00
Biosimilars have a very complex molecular structure and they have similar characteristics as compared to their reference medicine. Biosimilars are mainly used to derive known effective medicinal produ...
June 2020
256 pages
Japan Biosimilars- Landscape Today Outlook Tomorrow
US$ 4,500.00
“Biosame” entry, uninterrupted supply and companies’ strong front-end footprint requirement makes it distinctAfter a decade, JP Biosimilar guideline’s first revision expected in FY2020 –Demonstrate Ch...
January 2020
156 pages
Europe Biosimilar Insulin Glargine & Lispro Market, By End User (Type 1 Diabetes and Type 2 Diabetes),By Country (Germany, United Kingdom, France, Italy, Spain, Russia, Turkey, Poland, The Netherlands, Austria & Rest of Europe), Competition, Forecast & Opportunities, 2024
US$ 4,000.00
Europe biosimilar insulin glargine and lispro market is projected to reach $ 1.9 billion by 2024 owing to rising levels of obesity, growing expenditure on healthcare and increasing adoption of sedenta...
January 2020
86 pages
Predisposition Biomarkers: Technologies and Global Markets
US$ 3,950.00
REPORT INCLUDES: An overview of technologies and global markets for the predisposition biomarkersAnalyses of the global market trends with data from 2018, estimates for 2019, and projections of compo...
October 2019
72 pages
Asia Pacific Cardiac Biomarkers Testing Market 2019-2025)
US$ 1,500.00
The Asia Pacific Cardiac Biomarkers Testing Market would witness market growth of 12.8% CAGR during the forecast period (2019–2025). Asia Pacific would emerge as ... of the most lucrative regions for Cardiac Biomarkers testing market. Prime factor fueling the growth of Asia Pacific region includes the presence of ...
June 2019
104 pages
Europe Cardiac Biomarkers Testing Market (2019-2025)
US$ 1,500.00
The Europe Cardiac Biomarkers Testing Market would witness market growth of 11.1% CAGR during the forecast period (2019–2025). The ability of cardiac markers for accurate and rapid prediction ...
June 2019
104 pages
Global Cardiac Biomarkers Testing Market (2019-2025)
US$ 3,600.00
The Global Cardiac Biomarkers Testing Market size is expected to reach $16.2 billion by 2025, rising at a market growth of 11.4% CAGR during the forecast period. Cardiac biomarkers or cardiac markers are endogenous substances which are ...
June 2019
250 pages
US Biosimilars Market, Dosage, Price & Clinical Pipeline Outlook 2025
US$ 2,400.00
... Phase: 28 Biosimilars Marketed Biosimilars Clinical Insight by Company & Indication: 9 Biosimilars Biosimilars Market Opportunity: US$ 5 Billion FDA Rules & Regulations For Biosimilars Development & Market Approved & Marketed Biosimilars: Clinical Insight, Price & Dosage 'US Biosimilars Market, Dosage, Price ...
April 2019
300 pages
Global Cardiac Biomarkers Market Size study, by type (Myocardial muscle Creatine Kinase, Myoglobin, Troponins (T and I), Ischemia Modified Albumin (IMA), Brain Natriuretic Peptide (BNPs) or NT-proBNP and Others) Application (myocardial infarction, congestive heart failure, acute coronary syndrome, Atherosclerosis, other applications) Location of Testing (point of care testing and laboratory testing) and Regional Forecasts 2018-2025.
US$ 3,750.00
... are responsible for the wide adoption of cardiac biomarkers globally. Global cardiac biomarker market is majorly driven by rising prevalence of cardiovascular ... Target Audience of the Global Cardiac Biomarkers Market in Market Study: Key Consulting Companies & Advisors Large, medium-sized, and small enterprises ...
February 2019
200 pages
Global G-CSF Biosimilars Market Size study, by Type (Human Growth Hormone, Erythropoietin, Monoclonal Antibodies, Insulin, Interferon, Granulocyte-Colony Stimulating Factor), By Application (Blood Disorders, Oncology Diseases, Chronic and Autoimmune Diseases, Growth Hormone Deficiencies) and Regional Forecasts 2018-2025
US$ 3,750.00
... – 2018 to 2025 Target Audience of the Global G-CSF Biosimilars Market in Market Study: Key Consulting Companies & Advisors Large, medium-sized, and small enterprises Venture capitalists Value ...
February 2019
200 pages
Global Non-alcoholic Steatohepatitis Biomarkers Market Forecast, 2018-2023
US$ 3,600.00
... government policies impacting the global non-alcoholic steatohepatitis biomarkers market. Insights about market determinants which are stimulating the global non-alcoholic steatohepatitis biomarkers market. Detailed and extensive market segments with regional distribution ...
January 2019
-
Global Multiplex Biomarker Imaging Market (2018–2023)
US$ 2,950.00
... global multiplex biomarker imaging market is projected to expand at a compound annual growth rate (CAGR) of 12.0% during the 2018–2023 period, generating a revenue of USD 523.59 Mn by 2023. The global multiplex biomarker imaging market ... insights: The global multiplex biomarker imaging market can be segmented ...
January 2019
90 pages
Global Adult Stem Cells Industry Market Research Report
US$ 2,960.00
The Adult Stem Cells market revenue was xx.xx Million USD in 2013, grew to xx.xx Million USD in 2017, and will reach xx.xx Million USD in 2023, with a CAGR of x.x% during 2018-2023. Based on the Adult...
January 2019
128 pages
Artificial Organs: Market Research Report
US$ 5,600.00
... the worldwide markets for Artificial Organs in US$ Million by the following Product Segments: Artificial Heart, Artificial Kidneys, Artificial Liver, Artificial Pancreas, and Artificial Lungs. ... five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and ...
January 2019
201 pages
Biosimilars: Market Research Report
US$ 5,450.00
This report analyzes the worldwide markets for Biosimilars in US$ Million. The report provides separate comprehensive analytics for the US, ... forecasts are provided for the period 2015 through 2022. Market data and analytics are derived from primary and secondary ...
January 2019
243 pages
Mesenchymal Stem Cells: Market Research Report
US$ 5,450.00
This report analyzes the worldwide markets for Mesenchymal Stem Cells in US$ Million. The report ... -year historic analysis is provided for these markets. Market data and analytics are derived from primary ... niche players such as - Aastrom Biosciences, Inc. Cell Applications, Inc. Celprogen, Inc. Cyagen US Inc. ...
December 2018
167 pages
Attractions for Japanese companies in the Global Stem Cell Market
US$ 3,750.00
The global stem cell market report segments the market by therapy, competition, and application area to name a few. The report also looks into the therapeutic pipeline across different segments such as cardiovascular, neurology, orthopedics, dermatology, etc. Lack of early stage funding and adaptability are ...
December 2018
100 pages
Attractions for Korean companies in the Global Stem Cell Market
US$ 3,750.00
The global stem cell market report segments the market by therapy, competition, and application area to name a few. The report also looks into the therapeutic pipeline across different segments such as cardiovascular, neurology, orthopedics, dermatology, etc. Lack of early stage funding and adaptability are ...
December 2018
100 pages
Delving into Stem Cell Research and its Potential 2018
US$ 850.00
... can differentiate into a wide range of specialized cell types. As stem cells can be readily grown and transformed into specialized cells with characteristics consistent with cells of various tissues ...
December 2018
155 pages
ASEAN and China Biosimilars Market by Molecule Type (Human Growth Hormone, Erythropoietin, Monoclonal Antibody, Insulin, Interferon, Granulocyte-Colony Stimulating Factor, and Peptide), and Application (Blood Disorder, Oncology Disease, Chronic & Autoimmune Disease, Growth Hormone Deficiency, and Others): Opportunity Analysis and Industry Forecast, 2017 - 2025
US$ 3,200.00
... the expansion of the biosimilars market across ASEAN and China. The ASEAN and China biosimilars market is segmented into molecule ... market is analyzed across China and ASEAN region. Key Benefits ASEAN and China Biosimilars Market: The study provides an in-depth analysis of the ASEAN and China biosimilars market ...
November 2018
130 pages
